| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Atlas Venture Associates X, L.P. is a 10% Owner at TECX, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 43 sales.
Our model assigns Atlas Venture Associates X, L.P. a strong insider score of 88/100, based on 18 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +69.6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2021 | GBIO Generation Bio Co. | 10% Owner | Sell | 81,088 | $25.40 | $2,059,519.16 | -99.3% | -67.6% | -79.0% | |
| Sep 24, 2021 | GBIO Generation Bio Co. | 10% Owner | Sell | 134,998 | $26.02 | $3,511,992.53 | -99.4% | -67.7% | -81.2% | |
| Aug 11, 2021 | KYMR Kymera Therapeutics, Inc. | 10% Owner | Sell | 242,133 | $61.00 | $14,770,113.00 | -100% | +15.6% | -42.7% | |
| Jun 24, 2021 | GBIO Generation Bio Co. | 10% Owner | Sell | 31,008 | $25.85 | $801,618.16 | -98.1% | -1.0% | -73.1% | |
| Jun 23, 2021 | GBIO Generation Bio Co. | 10% Owner | Sell | 185,078 | $25.05 | $4,635,967.02 | -99.6% | +1.6% | -72.7% | |
| Apr 14, 2021 | GBIO Generation Bio Co. | 10% Owner | Sell | 140,682 | $25.92 | $3,646,968.15 | -100% | -13.6% | -64.6% | |
| Apr 9, 2021 | GBIO Generation Bio Co. | 10% Owner | Sell | 127,095 | $28.20 | $3,583,860.22 | -47.5% | -6.8% | -67.8% | |
| Mar 12, 2021 | KYMR Kymera Therapeutics, Inc. | 10% Owner | Sell | 229,350 | $56.50 | $12,958,275.00 | -100% | -13.5% | -36.0% |